Article
Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
American journal of nephrology - 1 Jan 2008
Axelsson Jonas, Wang Xin, Ketteler Markus, Qureshi Abdul Rashid, Heimbürger Olof, Bárány Peter, Lindholm Bengt, Nordfors Louise, Stenvinkel Peter
Abstract excerpt
INTRODUCTION: Components of the metabolic syndrome are highly prevalent in chronic kidney disease (CKD) patients--some of which paradoxically appear to predict an improved outcome in this population. We hypothesized that the circulating calcification inhibitor fetuin-A/AHSG, which is also a natur...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
